Cochlear

DGAP-News: Precisis concludes funding round of €20 million for its bioelectric brain stimulation system

Thursday, October 14, 2021 - 12:08pm

Heidelberg, Germany, [14 October 2021] - Precisis AG, based in Heidelberg, announced that it has successfully concluded a funding round of 20 million with Cochlear Limited.

Key Points: 
  • Heidelberg, Germany, [14 October 2021] - Precisis AG, based in Heidelberg, announced that it has successfully concluded a funding round of 20 million with Cochlear Limited.
  • Precisis is a medical technology company that develops minimally invasive brain stimulation methods to relieve epilepsy patients from their symptoms.
  • The additional funding will be used to support ongoing clinical studies and to further advance EASEE(R), an implantable bioelectric brain stimulation system that explores novel approaches to treating epilepsy.
  • Angela Liedler, MD, CEO of Precisis AG, is thrilled: "This funding round is an important step in the advancement of bioelectric brain stimulation.

Australian Business Agility Specialist Expands Into North America

Thursday, September 30, 2021 - 2:00pm

SYDNEY and TORONTO, Sept. 30, 2021 /PRNewswire/ -- Business agility firm EPiC Agile is expanding into the Americas after bringing seasoned industry veteran Ron Laudadio onboard to continue its track record of exponential growth and global expansion.

Key Points: 
  • According to a recent study published by Accenture, more organisations are commencing a business agility journey and those on the journey report greater progress.
  • [1]
    EPiC Agile is a full-service business agility transformation company, with more than 60 coaches through South-East Asia who help companies successfully implement business agility models.
  • perTheir strategic implementation of business agility is unique and will be sought after by business leaders in this region."
  • The company works to help organisations successfully implement business agility models, and mentor business leaders as they pivot to more nimble ways of working.

Cochlear Foundation launches global partnership with Malala Fund to remove hearing loss as a barrier to education

Thursday, September 23, 2021 - 1:15pm

Following this important step, Malala Fund and Cochlear Foundation, supported by Cochlear, sought to ensure hearing loss is not yet another reason girls, marginalized people and those who need hearing healthcare and support are left behind.

Key Points: 
  • Following this important step, Malala Fund and Cochlear Foundation, supported by Cochlear, sought to ensure hearing loss is not yet another reason girls, marginalized people and those who need hearing healthcare and support are left behind.
  • "Cochlear Foundation is committed to supporting organizations and programs that enrich the lives of people with hearing loss and their communities, increase research into hearing loss and support hearing health professionals."
  • Malala Fund and Cochlear Foundation are inviting children and young people with hearing loss to share their stories of personal achievement as part of the 'Achieve anything program.'
  • Cochlear Foundation is a hearing health not-for-profit, supported by Cochlear, which aims to raise awareness of hearing loss and help more people around the world access life-changing hearing treatment.

Oticon Medical Announces FDA Premarket Approval for Neuro Cochlear Implant System to Treat Severe to Profound Sensorineural Hearing Loss

Thursday, June 24, 2021 - 3:07pm

With the expansion of its cochlear implant solutions to the US market, Oticon Medical is well positioned to become the worlds leading hearing expert within implantable hearing solutions.

Key Points: 
  • With the expansion of its cochlear implant solutions to the US market, Oticon Medical is well positioned to become the worlds leading hearing expert within implantable hearing solutions.
  • People with severe to profound hearing loss in 51 countries already benefit from the Neuro System.
  • View the full release here: https://www.businesswire.com/news/home/20210624005685/en/
    Oticon Medical announces that the US Food and Drug Administration (FDA) has granted Premarket Approval (PMA) for the Neuro Cochlear Implant System to treat severe to profound sensorineural hearing loss.
  • The Neuro System is the first new cochlear implant technology to earn FDA premarket approval in more than 20 years.

Fennec Pharmaceuticals Announces First Quarter 2021 Financial Results and Provides Business Update

Thursday, May 13, 2021 - 11:00am

The incidence of ototoxicity depends upon the dose and duration of chemotherapy, and many of these children require lifelong hearing aids.

Key Points: 
  • The incidence of ototoxicity depends upon the dose and duration of chemotherapy, and many of these children require lifelong hearing aids.
  • There is currently no established preventive agent for this hearing loss and only expensive, technically difficult and sub-optimal cochlear (inner ear) implants have been shown to provide some benefit.
  • For more information, please visit www.fennecpharma.com\nExcept for historical information described in this press release, all other statements are forward-looking.
  • Fennec disclaims any obligation to update these forward-looking statements except as required by law.\nFor a more detailed discussion of related risk factors, please refer to our public filings available at www.sec.gov and www.sedar.com .\n'

New Cochlear CoPilot app to help adults improve hearing outcomes through skills training

Monday, May 3, 2021 - 2:07pm

b'LONE TREE, Colo., May 3, 2021 /PRNewswire/ --Adults with cochlear implants may be able to improve their listening and communications skills in daily life with the help of a new self-guided digital tool by Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions.\nCochlear CoPilot is a new mobile app to improve hearing techniques.

Key Points: 
  • b'LONE TREE, Colo., May 3, 2021 /PRNewswire/ --Adults with cochlear implants may be able to improve their listening and communications skills in daily life with the help of a new self-guided digital tool by Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions.\nCochlear CoPilot is a new mobile app to improve hearing techniques.
  • "With CoPilot, I love the little listening exercises that help me work on word recognition.
  • "\n"At Cochlear, we are committed to improving our service and support offerings to help meet the changing needs of our hearing implant recipients," said Ren Courtney, Vice President & General Manager, Recipient Services, Cochlear Americas.
  • The addition of Cochlear CoPilot provides cochlear implant recipients with a simple mobile app to help them build their listening and communication skills from the palm of their hand, so they can be better equipped to hear wherever their day may take them.

Cochlear Implant System Market Revenue to Cross USD 2.2B by 2027: Global Market Insights, Inc.

Thursday, February 25, 2021 - 9:00am

SELBYVILLE, Del., Feb. 25, 2021 /PRNewswire/ --According to the latest report "Cochlear Implant System Market by Product (Unilateral Implant, Bilateral Implant), End-user (Adult, Pediatric), Regional Outlook, Price Trends, Competitive Market Share & Forecast 2027", by Global Market Insights, Inc., the market valuation of cochlear implant systems will cross $2.2 billion by 2027.

Key Points: 
  • SELBYVILLE, Del., Feb. 25, 2021 /PRNewswire/ --According to the latest report "Cochlear Implant System Market by Product (Unilateral Implant, Bilateral Implant), End-user (Adult, Pediatric), Regional Outlook, Price Trends, Competitive Market Share & Forecast 2027", by Global Market Insights, Inc., the market valuation of cochlear implant systems will cross $2.2 billion by 2027.
  • For instance, in December 2020, Advanced Bionics that collaborated with Phonak received the U.S. FDA approval for their cochlear implant product.
  • The increasing prevalence of hearing loss and impairment will contribute to the cochlear implant system market demand.
  • The pediatric segment in the cochlear implant system market accounted for USD 580 million in 2020.

Cochlear announces 2021 winners of annual scholarships

Wednesday, February 3, 2021 - 2:06pm

LONE TREE, Colo., Feb. 3, 2021 /PRNewswire/ --Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, announced today the winners of the 19th annual Graeme Clark and the 10th annual Anders Tjellstrm Scholarships.

Key Points: 
  • LONE TREE, Colo., Feb. 3, 2021 /PRNewswire/ --Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, announced today the winners of the 19th annual Graeme Clark and the 10th annual Anders Tjellstrm Scholarships.
  • The scholarships, named after two pioneers of the hearing implant industry, recognize Cochlear Nucleus Implant, Cochlear Baha System and Cochlear Osia System recipients in the United States and Canada who uphold the Cochlear ideals of leadership, humanity, and demonstrate high academic achievement.
  • Cochlear announces 2021 winners of annual scholarships, recognizing young leaders in the hearing loss community.
  • "We are honored to recognize the accomplishments of these eight exceptional Cochlear recipients," said Ren Courtney, Vice President & General Manager, Recipient Services, Cochlear Americas.

Sensorion Announces Preclinical Data Demonstrating SENS-401’s Potential to Preserve Residual Hearing After Cochlear Implantation

Tuesday, January 19, 2021 - 6:30am

But preserving acoustic hearing in patients with less severe forms of hearing loss who receive cochlear implants could provide a substantial benefit to this population, said Nawal Ouzren, CEO of Sensorion.

Key Points: 
  • But preserving acoustic hearing in patients with less severe forms of hearing loss who receive cochlear implants could provide a substantial benefit to this population, said Nawal Ouzren, CEO of Sensorion.
  • The preclinical program was conducted as part of a collaboration between Sensorion and Cochlear (ASX: COH), the global leader in implantable hearing solutions.
  • The study was designed to determine whether SENS-401 has the potential to improve preservation of residual acoustic hearing after cochlear implantation.
  • Either SENS-401 or a placebo was delivered via an eluting electrode in an established pre-clinical model of cochlear implantation.

Global Cochlear Implants Market Research 2021-2025 | Post-Pandemic Industry Planning Structure | Technavio

Wednesday, December 30, 2020 - 3:23am

The cochlear implants market is poised to grow by USD 1.32 billion during 2021-2025, progressing at a CAGR of almost 12% during the forecast period.

Key Points: 
  • The cochlear implants market is poised to grow by USD 1.32 billion during 2021-2025, progressing at a CAGR of almost 12% during the forecast period.
  • View the full release here: https://www.businesswire.com/news/home/20201229005470/en/
    Technavio has announced its latest market research report titled Global Cochlear Implants Market 2021-2025 (Graphic: Business Wire)
    Worried about the impact of COVID-19 on your Business?
  • The report on the cochlear implants market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.
  • The cochlear implants market analysis includes the product, geography, and key vendors.